Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
1. The disposition of a new beta-blocking agent, chloropractolol, labelled with 14C and with 3H, has been studied in rats and mice. 2. After i.v. administration to the rat (25 mg/kg) of a mixture of [14C]- and [3H]chloropractolol, urinary and faecal excretion, biliary elimination and tissue distribution were similar for the two labelled species. However, 3% of the dose was recovered as 14CO2. 3. Chloropractolol and/or metabolites did not show high cardioselectivity. Uptake by heart of the two labelled species was very close to that found for [14C]practolol and [14C]propranolol. 4. Preliminary metabolic studies using h.p.l.c. have shown that in the rat chloropractolol is extensively metabolized, which contrasts with the more limited metabolism of practolol in the same species. Deacetylation is a minor route of metabolism. A structure for the main urinary metabolite is suggested.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000478:Alkylation; D000818:Animals; D001646:Bile / Q000378:metabolism; D008297:Male; D051379:Mice; D011217:Practolol / Q000031:analogs & derivatives* / Q000378:metabolism; D051381:Rats; D014018:Tissue Distribution
D000319:Adrenergic beta-Antagonists; C027967:chloropractolol; D011217:Practolol